Mucoadhesive controlled release microcapsules of indomethacin: Optimization and stability study

References

• Aiedeh K, Orienti I, Bertasj V, Zecchi V. Chitosan and chitosan linked to triethylene glycol glutarate or betain as tableting excipients for the sustained release of indomethacin. STP Pharma Sci 1998; 8: 291–296
   Google Scholar
• Allen LV, Popovich NG, Ansel HC. Pharmaceutical dosage forms and drug delivery systems8th. Lippincott Williams and Wilkins, Philadelphia, PA 2005
   Google Scholar
• Attama AA, Adikwu MU, Amorha CJ. Release of indomethacin from bioadhesive tablets containing Carbopol® 941 modified with Abelmuschus esculentus (Okra) gum. Boll Chim-Farm 2003; 142: 298–302
   PubMedGoogle Scholar
• Beyssac E, Aiache JM, Caplain H, Dovin MJ, Renoux A. Proceedings of the 21st Annual CRS International Symposium on Bioactive Materials, Nice, France 1994; 21: 891–892
   Google Scholar
• Chan LW, Heng PWS, Wan LSC. Effect of cellulose derivatives on alginate microspheres prepared by emulsification. J Microencapsulation 1997; 14: 545–555
   PubMed Web of Science ®Google Scholar
• Chowdary KR, Rao YS, 2003a. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. AAPS PharmSciTech 4:article 39
   Google Scholar
• Chowdary KR, Rao YS. Preparation and evaluation of mucoadhesive microcapsules of indomethacin. Indian J Pharm Sci 2003b; 65: 49–52
   Google Scholar
• Cornell J. Experiments with mixtures: Designs, models, and the analysis of mixture data. John Wiley & Sons, New York 2002
   Google Scholar
• FDA (US Food and Drug Administration). 2003. PAT—a framework for innovative pharmaceutical manufacturing and quality assurance. In: Pharmaceutical cGMPs for the 21st Century—a risk-based approach: Second progress report and implementation plan. Available online at: http://www.fda.gov/cder/guidance/5815dft.htm (January 15, 2009)
   Google Scholar
• Hosmani AH, 2006. Carbopol and its pharmaceutical significance: A review. Latest Reviews 4:article 2
   Google Scholar
• Ikeda K, Murata K, Kobayashi M, Noda K. Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull 1992; 40: 2155–2158
   PubMed Web of Science ®Google Scholar
• Illum L. Bioadhesive formulations for nasal peptide delivery In Mathiowitz E, Chickering III DE, Lehr C-M, editors. 1999, Bioadhesive drug delivery systems: Fundamentals, novel approaches, and development. 1st ed. New York: Informa Healthcare. pp 507–540
   Google Scholar
• Illum L, Farraj NF, Critcheley H, Davis SS. Nasal administration of gentamicin using a novel microsphere delivery system. Int J Pharm 1988; 46: 261–265
   Web of Science ®Google Scholar
• Ishmael J, Suresh V. Indomethacin sustained release from alginate-gelatin or pectin-gelatin coacervates. Int J Pharm 1995; 126: 161–168
   Google Scholar
• Kamath KR, Park K. Mucosal adhesive preparation, In Swarbrick J, Boylan JC, editors. 1994, Encyclopedia of pharmaceutical technology. Vol 10. New York: Marcel Dekker. pp 133–136
   Google Scholar
• Kopecek J, Kopecková P, Brondsted H, Rathi R, Rihová B, Yeh P-Y, Ikesue K. Polymers for colon-specific drug delivery. J Contr Rel 1992; 19: 121–130
   Web of Science ®Google Scholar
• Lele BS, Hoffman AS. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. J Contr Rel 2000; 69: 237–248
   PubMed Web of Science ®Google Scholar
• Minitab Statistical Software®, version 13 manual. 2000. State College, PA: Minitab Inc.
   Google Scholar
• Montgomery DC. Design and analysis of experiments4th. John Wiley & Sons, New York 1997
   Google Scholar
• Morimoto K, Yamaguchi H, Iwakura Y, Morisaka K, Ohashi Y, Nakai Y. Effects of viscous hyaluronate sodium solutions on the nasal absorption of vasopressin and an analogue. Pharm Res 1991; 8: 471–474
   PubMed Web of Science ®Google Scholar
• Myers RH, Montgomery DC. Response surface methodology: Process and product optimization using designed experiments. John Wiley & Sons, New York 2002
   Google Scholar
• Nagai T, Nishimoto Y, Nambu N, Suzuki Y, Sekine K. Powder dosage forms of insulin for nasal administration. J Contr Rel 1984; 1: 15–22
   Google Scholar
• Pornsak S, Jurairat N. Calcium pectinate gel beads for controlled release drug delivery: I. preparation and in vitro release studies. Int J Pharm 1998; 160: 207–212
   Google Scholar
• Rihová B, Rathi RC, Kopecková P, Kopecek J. Bioadhesive polymers for oral drug delivery. Adv Exp Med Biol 1995; 371B: 1491–1494
   PubMedGoogle Scholar
• Santos CA, Jacob JS, Hertzog BA, Freedman BD, Press DL, Harnpicharnchai P, Mathiowitz E. Correlation of two bioadhesion assays: The everted sac technique and the CAHN microbalance. J Contr Rel 1999; 61: 113–122
   PubMed Web of Science ®Google Scholar
• Shiraishi S, Imai T, Otagiri M. Controlled release of indomethacin by chitosan-polyelectrolyte complex: Optimization and in vivo/in vitro evaluation. J Contr Rel 1993; 25: 217–222
   Web of Science ®Google Scholar
• Singh SK, Dodge J, Durrani MJ, Khan MA. Optimization and characterization of controlled release pellets coated with an experimental latex: I. anionic drug. Int J Pharm 1995; 125: 243–255
   Web of Science ®Google Scholar
• Somasundaran P, ed. Encyclopedia of surface and colloid science, 2nd ed. Taylor & Francis, Boca Raton, FL 2006; 3963–3965
   Google Scholar
• Takeuchi K, Watanabe M, Yanagi M, Murakami I, Hosono H, Nishizawa S, Chigono Y, Hirabayashi S, Matsuda J, Yamaoka K, Inoue K, 2008. In vitro and clinical evaluation of an oral mucosal adhesive film containing indomethacin. Yakugaku Zasshi 128:1791–1795
   Google Scholar
• Tanabe M, Watanabe M, Yanagi M, Nishizawa S, Chigono Y, Matsuda J, Yamaoka K, Inoue K. Controlled indomethacin release from mucoadhesive film: In vitro and clinical evaluations. Yakugaku Zasshi 2008; 128: 1673–1679
   PubMed Web of Science ®Google Scholar
• US Pharmacopoeia 30, NF 25, 2007. Rockville, MD: United States Pharmacopoeial Convention Inc
   Google Scholar
• Waaler PJ, Graffner C, Muller BW. Optimization of a matrix tablet formulation using a mixture design. Acta Pharm Nord 1992; 4: 9–16
   PubMedGoogle Scholar
• Yoo MK, Choi HK, Kim TH, Choi YJ, Akaike T, Shirakawa M, Cho CS. Drug release from xyloglucan beads coated with Eudragit for oral drug delivery. Arch Pharm Res 2005; 28: 736–742
   PubMed Web of Science ®Google Scholar